share_log

6-K: Novo Nordisk A/S - Share Repurchase Programme

6-K: Novo Nordisk A/S - Share Repurchase Programme

6-K：諾和諾德-股票回購計劃
美股SEC公告 ·  09/17 01:32
牛牛AI助理已提取核心訊息
Novo Nordisk A/S, a leading global healthcare company, has been actively executing its share repurchase program, which was announced on August 7, 2024. The program is part of a larger plan to buy back shares worth up to DKK 20 billion over a 12-month period starting from February 6, 2024. As of September 13, 2024, Novo Nordisk has repurchased 12,235,249 B shares at an average price of DKK 881.30 per share, totaling DKK 10,782,912,990. The transactions made under this program are detailed on the company's website. With the recent purchases, Novo Nordisk now holds 13,563,880 B shares as treasury shares, which is 0.3% of the share capital. The company's total share count, including treasury shares, stands at 4,465,000,000. Novo Nordisk's shares are traded on Nasdaq Copenhagen and its ADRs on the New York Stock Exchange.
Novo Nordisk A/S, a leading global healthcare company, has been actively executing its share repurchase program, which was announced on August 7, 2024. The program is part of a larger plan to buy back shares worth up to DKK 20 billion over a 12-month period starting from February 6, 2024. As of September 13, 2024, Novo Nordisk has repurchased 12,235,249 B shares at an average price of DKK 881.30 per share, totaling DKK 10,782,912,990. The transactions made under this program are detailed on the company's website. With the recent purchases, Novo Nordisk now holds 13,563,880 B shares as treasury shares, which is 0.3% of the share capital. The company's total share count, including treasury shares, stands at 4,465,000,000. Novo Nordisk's shares are traded on Nasdaq Copenhagen and its ADRs on the New York Stock Exchange.
諾和諾德（Novo Nordisk A/S）是一家領先的全球醫療保健公司，積極執行其股份回購計劃，該計劃於2024年8月7日宣佈。該計劃是在爲期12個月的大型回購計劃的一部分，從2024年2月6日開始回購價值高達200億丹麥克朗的股份。截至2024年9月13日，諾和諾德已回購了122352490億股，平均每股回購價爲881.30丹麥克朗，總價爲107,829,129,900丹麥克朗。該計劃下進行的交易細節可在公司網站上找到。最近的收購使諾和諾德現在持有135638800億股作爲庫藏股，佔股本的0.3%。該公司的總股數，包括庫藏股，在446.5億股。諾和諾德的股票在納斯達克哥本哈根上市，其ADR在紐約證券交易所交易。
諾和諾德（Novo Nordisk A/S）是一家領先的全球醫療保健公司，積極執行其股份回購計劃，該計劃於2024年8月7日宣佈。該計劃是在爲期12個月的大型回購計劃的一部分，從2024年2月6日開始回購價值高達200億丹麥克朗的股份。截至2024年9月13日，諾和諾德已回購了122352490億股，平均每股回購價爲881.30丹麥克朗，總價爲107,829,129,900丹麥克朗。該計劃下進行的交易細節可在公司網站上找到。最近的收購使諾和諾德現在持有135638800億股作爲庫藏股，佔股本的0.3%。該公司的總股數，包括庫藏股，在446.5億股。諾和諾德的股票在納斯達克哥本哈根上市，其ADR在紐約證券交易所交易。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。